M. Dodson Michael

726 total citations
19 papers, 592 citations indexed

About

M. Dodson Michael is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, M. Dodson Michael has authored 19 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 11 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Molecular Biology. Recurrent topics in M. Dodson Michael's work include Pancreatic function and diabetes (11 papers), Diabetes Treatment and Management (9 papers) and Diabetes Management and Research (5 papers). M. Dodson Michael is often cited by papers focused on Pancreatic function and diabetes (11 papers), Diabetes Treatment and Management (9 papers) and Diabetes Management and Research (5 papers). M. Dodson Michael collaborates with scholars based in United States, Australia and Spain. M. Dodson Michael's co-authors include Kyle W. Sloop, James Ficorilli, Daniel A. Briere, Amy L. Cox, Tamer Coşkun, Vikram Sinha, Angela M. Siesky, Mary Courtney Moore, Hong Gao and Scott J. Jacober and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

M. Dodson Michael

19 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Dodson Michael United States 13 293 285 212 134 94 19 592
Mako Yasuda‒Yamahara Japan 15 152 0.5× 225 0.8× 246 1.2× 175 1.3× 77 0.8× 24 694
Yukiko Kanda Japan 12 304 1.0× 304 1.1× 209 1.0× 125 0.9× 116 1.2× 20 611
Chikage Sato Japan 8 146 0.5× 290 1.0× 169 0.8× 62 0.5× 67 0.7× 9 551
Sabine Rütti Switzerland 11 329 1.1× 247 0.9× 230 1.1× 165 1.2× 147 1.6× 16 678
Hidemitsu Sakagami Japan 8 182 0.6× 206 0.7× 206 1.0× 83 0.6× 36 0.4× 13 515
Yasutaka Takeda Japan 9 181 0.6× 231 0.8× 171 0.8× 73 0.5× 36 0.4× 20 454
Sandra Slusher United States 7 177 0.6× 138 0.5× 359 1.7× 133 1.0× 167 1.8× 8 653
Masahiro Hiratochi Japan 10 182 0.6× 272 1.0× 293 1.4× 91 0.7× 33 0.4× 15 593
Günaj Rakipovski Denmark 9 137 0.5× 363 1.3× 211 1.0× 69 0.5× 156 1.7× 15 547
Kazuhito Tawaramoto Japan 11 262 0.9× 276 1.0× 186 0.9× 62 0.5× 61 0.6× 18 479

Countries citing papers authored by M. Dodson Michael

Since Specialization
Citations

This map shows the geographic impact of M. Dodson Michael's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Dodson Michael with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Dodson Michael more than expected).

Fields of papers citing papers by M. Dodson Michael

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Dodson Michael. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Dodson Michael. The network helps show where M. Dodson Michael may publish in the future.

Co-authorship network of co-authors of M. Dodson Michael

This figure shows the co-authorship network connecting the top 25 collaborators of M. Dodson Michael. A scholar is included among the top collaborators of M. Dodson Michael based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Dodson Michael. M. Dodson Michael is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
He, Rongjun, Jifeng Wang, Zhihong Yu, et al.. (2022). Structure-Based Design of Active-Site-Directed, Highly Potent, Selective, and Orally Bioavailable Low-Molecular-Weight Protein Tyrosine Phosphatase Inhibitors. Journal of Medicinal Chemistry. 65(20). 13892–13909. 5 indexed citations
2.
Chen, Yen‐Shan, Yanwu Yang, Balamurugan Dhayalan, et al.. (2021). Insertion of a synthetic switch into insulin provides metabolite-dependent regulation of hormone–receptor activation. Proceedings of the National Academy of Sciences. 118(30). 14 indexed citations
3.
Cox, Amy L., Eric D. Hawkins, Jie Xue, et al.. (2020). Insulin, Not the Preservative m-cresol, Instigates Loss of Infusion Site Patency Over Extended Durations of CSII in Diabetic Swine. Journal of Pharmaceutical Sciences. 110(3). 1418–1426. 10 indexed citations
4.
Garibay, Darline, Seon A Lee, Leanne R. Donahue, et al.. (2018). β Cell GLP-1R Signaling Alters α Cell Proglucagon Processing after Vertical Sleeve Gastrectomy in Mice. Cell Reports. 23(4). 967–973. 23 indexed citations
5.
Moyers, Julie S., Catherine B. Volk, Chen Zhang, et al.. (2017). Internalization and localization of basal insulin peglispro in cells. Molecular and Cellular Endocrinology. 454. 23–38. 1 indexed citations
6.
Byrd, Richard A., Rebecca A. Owens, Jamie L. Blackbourne, et al.. (2017). Nonclinical pharmacology and toxicology of the first biosimilar insulin glargine drug product (BASAGLAR®/ABASAGLAR®) approved in the European Union. Regulatory Toxicology and Pharmacology. 88. 56–65. 4 indexed citations
7.
Peterson, Richard G., et al.. (2017). Glucose dysregulation and response to common anti-diabetic agents in the FATZO/Pco mouse. PLoS ONE. 12(6). e0179856–e0179856. 27 indexed citations
8.
Droz, Brian A., Charles V. Jackson, M. Dodson Michael, et al.. (2017). Correlation of disease severity with body weight and high fat diet in the FATZO/Pco mouse. PLoS ONE. 12(6). e0179808–e0179808. 14 indexed citations
9.
Briere, Daniel A., et al.. (2017). Mechanisms to Elevate Endogenous GLP-1 Beyond Injectable GLP-1 Analogs and Metabolic Surgery. Diabetes. 67(2). 309–320. 46 indexed citations
10.
Garibay, Darline, Anne K. McGavigan, Seon A Lee, et al.. (2016). β-Cell Glucagon-Like Peptide-1 Receptor Contributes to Improved Glucose Tolerance After Vertical Sleeve Gastrectomy. Endocrinology. 157(9). 3405–3409. 49 indexed citations
11.
Knadler, Mary Pat, Tri‐Hung Nguyen, Kristina Campanale, et al.. (2016). Addition of 20-kDa PEG to Insulin Lispro Alters Absorption and Decreases Clearance in Animals. Pharmaceutical Research. 33(12). 2920–2929. 7 indexed citations
12.
Briere, Daniel A., Xiaoping Ruan, Christine C. Cheng, et al.. (2015). Novel Small Molecule Agonist of TGR5 Possesses Anti-Diabetic Effects but Causes Gallbladder Filling in Mice. PLoS ONE. 10(8). e0136873–e0136873. 66 indexed citations
13.
Jun, Lucy S., Aaron D. Showalter, Feihan F. Dai, et al.. (2014). A Novel Humanized GLP-1 Receptor Model Enables Both Affinity Purification and Cre-LoxP Deletion of the Receptor. PLoS ONE. 9(4). e93746–e93746. 25 indexed citations
14.
Jun, Lucy S., Rohn Millican, Eric D. Hawkins, et al.. (2014). Absence of Glucagon and Insulin Action Reveals a Role for the GLP-1 Receptor in Endogenous Glucose Production. Diabetes. 64(3). 819–827. 49 indexed citations
15.
Moore, Mary Courtney, Marta S. Smith, Vikram Sinha, et al.. (2013). Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect on Glucose Metabolism. Diabetes. 63(2). 494–504. 68 indexed citations
16.
Pandey, Sanjay K., Xing Yu, Lynnetta M. Watts, et al.. (2007). Reduction of Low Molecular Weight Protein-tyrosine Phosphatase Expression Improves Hyperglycemia and Insulin Sensitivity in Obese Mice. Journal of Biological Chemistry. 282(19). 14291–14299. 61 indexed citations
17.
Sloop, Kyle W., Aaron D. Showalter, Amy L. Cox, et al.. (2007). Specific Reduction of Hepatic Glucose 6-Phosphate Transporter-1 Ameliorates Diabetes while Avoiding Complications of Glycogen Storage Disease. Journal of Biological Chemistry. 282(26). 19113–19121. 10 indexed citations
18.
Chouinard, Michael, Amy L. Cox, James Ficorilli, et al.. (2006). Farnesoid X Receptor Agonist Reduces Serum Asymmetric Dimethylarginine Levels through Hepatic Dimethylarginine Dimethylaminohydrolase-1 Gene Regulation. Journal of Biological Chemistry. 281(52). 39831–39838. 73 indexed citations
19.
Foxworthy, Patricia, Angela M. Siesky, James Ficorilli, et al.. (2005). Hepatic Peroxisomal Fatty Acid β-Oxidation Is Regulated by Liver X Receptor α. Endocrinology. 146(12). 5380–5387. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mako Yasuda‒Yamahara Breakdown of academic impact, for papers by Yukiko Kanda Breakdown of academic impact, for papers by Chikage Sato Breakdown of academic impact, for papers by Sabine Rütti Breakdown of academic impact, for papers by Hidemitsu Sakagami Breakdown of academic impact, for papers by Yasutaka Takeda Breakdown of academic impact, for papers by Sandra Slusher Breakdown of academic impact, for papers by Masahiro Hiratochi Breakdown of academic impact, for papers by Günaj Rakipovski Breakdown of academic impact, for papers by Kazuhito Tawaramoto
Rankless by CCL
2026